Phase III Double-Blind, Placebo-Controlled Study of Gabapentin for the Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy, NCCTG N08C3 (Alliance)

BACKGROUND: Despite targeted antiemetics, data support an unmet need related to the management of delayed nausea and vomiting (NV). Promising pilot data informed this phase III trial evaluating gabapentin for delayed NV from highly emetogenic chemotherapy (HEC). METHODS: Participants were randomized...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer
Hauptverfasser: Barton, Debra L., Thanarajasingam, Gita, Sloan, Jeff A., Diekmann, Brent, Fuloria, Jyotsna, Kottschade, Lisa A., Lyss, Alan P., Jaslowski, Anthony J., Mazurczak, Miroslaw A., Blair, Scott C., Terstriep, Shelby, Loprinzi, Charles L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2014
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221473/
https://ncbi.nlm.nih.gov/pubmed/25043153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28892
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge